Close

TransMedics Group (TMDX) Announces Trading Halt as FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. GM
4. SPOT
5. AMZN
6. SHW
7. AAPL
8. IBM
9. NVDA
10. MINN


Go back to TransMedics Group (TMDX) Announces Trading Halt as FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System

TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System

April 6, 2021 7:05 AM EDT

ANDOVER, Mass., April 6, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that Nasdaq has halted trading of the company's common stock.

... More